Prof Dr V.B. Schrauwen - Hinderling

Springer, S., Basset-Sagarminaga, J., van de Weijer, T., Schrauwen-Hinderling, V. B., Backes, W. H., & Wierts, R. (2025). Improving image reconstruction to quantify dynamic whole-body PET/CT: Q.Clear versus OSEM. EJNMMI Physics, 12(1), Article 27. https://doi.org/10.1186/s40658-025-00736-5

Koene, E. J., Buziau, A. M., Cassiman, D., Cox, T. M., Bons, J., Scheijen, J. L. J. M., Schalkwijk, C. G., Meex, S. J., Saxena, A. R., Esler, W. P., Schrauwen-Hinderling, V. B., Schrauwen, P., & Brouwers, M. C. (2025). Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance. Journal of Clinical Investigation, 135(6), Article e187376. https://doi.org/10.1172/JCI187376

de Wit-Verheggen, V. H. W., Wefers, J., Remie, C. M. E., Schrauwen, P., Schrauwen-Hinderling, V. B., & van de Weijer, T. (2025). Cardiac energy metabolism is decreased in male volunteers with prediabetes and does not normalize during the day. Physiological Reports, 13(5), Article e70242. https://doi.org/10.14814/phy2.70242

Kupriyanova, Y., Yurchenko, I., Bobrov, P., Bartels, F., Wierichs, S., Jonuscheit, M., Korzekwa, B., Prystupa, K., Schoen, M., Mendez, D., Trenkamp, S., Burkart, V., Wagner, R., Schrauwen-Hinderling, V., Roden, M., & German Diabetes Study (GDS) Group (2025). Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes. BMJ Open Diabetes Research & Care, 13(1), Article e004727. https://doi.org/10.1136/bmjdrc-2024-004727

op den Kamp-bruls, Y. M. H., op den Kamp, Y. J. M., Veeraiah, P., Perez, R. Z., Phielix, E., Havekes, B., Schaart, G., Kornips, E., Berendsen, B. R. B., Virmani, A., Wildberger, J. E., Houtkooper, R. H., Hesselink, M. K. C., Schrauwen, P., & Schrauwen-Hinderling, V. B. (2025). Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes Obesity & Metabolism, 27(5), 2864-2877. Advance online publication. https://doi.org/10.1111/dom.16298

Schrauwen-Hinderling, V. B., & Floegel, U. (2025). Editorial for "Evaluation of Hepatic Glucose and Palmitic Acid Metabolism in Rodents on High-Fat Diet Using Deuterium Metabolic Imaging". Journal of Magnetic Resonance Imaging, 61(2), 968-969. https://doi.org/10.1002/jmri.29512

Pesta, D., Anadol-Schmitz, E., Sarabhai, T., op den Kamp, Y., Gancheva, S., Trinks, N., Zaharia, O.-P., Mastrototaro, L., Lyu, K., Habets, I., op den Kamp-bruls, Y. M. H., Dewidar, B., Weiss, J., Schrauwen-Hinderling, V., Zhang, D., Gaspar, R. C., Strassburger, K., Kupriyanova, Y., Al-Hasani, H., ... Roden, M. (2025). Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals. Science advances, 11(1), Article eadr8849. https://doi.org/10.1126/sciadv.adr8849

Mevenkamp, J., Bruls, Y. M. H., Mancilla, R., Grevendonk, L., Wildberger, J. E., Brouwers, K., Hesselink, M. K. C., Schrauwen, P., Hoeks, J., Houtkooper, R. H., Buitinga, M., de Graaf, R. A., Lindeboom, L., & Schrauwen-Hinderling, V. B. (2024). Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T. Nature Communications, 15(1), Article 9159. https://doi.org/10.1038/s41467-024-53292-4

Zaharia, O. P., Strassburger, K., Knebel, B., Binsch, C., Kupriyanova, Y., Möser, C., Bódis, K., Prystupa, K., Yurchenko, I., Mendez Cardenas, D. M., Schön, M., Herder, C., Al-Hasani, H., Schrauwen-Hinderling, V., Jandeleit-Dahm, K., Wagner, R., & Roden, M. (2024). Role of patatin-like phospholipase domain-containing 3 gene for decreasing kidney function in recently diagnosed diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 18(10), Article 103137. https://doi.org/10.1016/j.dsx.2024.103137

Schaefer, E., Lang, A., Kupriyanova, Y., Bodis, K. B., Weber, K. S., Buyken, A. E., Barbaresko, J., Koessler, T., Kahl, S., Zaharia, O.-P., Szendroedi, J., Herder, C., Schrauwen-Hinderling, V. B., Wagner, R., Kuss, O., Roden, M., Schlesinger, S., & GDS Group (2024). Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower visceral and hepatic lipid content in recent-onset type 1 diabetes and type 2 diabetes. Diabetes Obesity & Metabolism, 26(10), 4281-4292. https://doi.org/10.1111/dom.15772